Search

everythinglearnresearchcommunity

for

Search:↓

Some patients taking finasteride or dutasteride may have ongoing sexual problems and depression even after stopping the medication.

Some skin conditions may indicate metabolic syndrome, which could help with early detection and management of related health issues.

Men with early-onset baldness have a higher chance of heart disease and clogged arteries.

Progesterone treatment improved seizures in a woman with menstrual cycle-related epilepsy, but a wrong medication worsened her condition.

Psychotropic medications can cause skin problems but also treat some skin conditions.

Topical melatonin is a safe treatment that may reduce hair loss in people with androgenetic alopecia.

Repurposing existing drugs for COVID-19 shows promise but requires more research to confirm effectiveness.

Certain genetic variations in the RAB5B gene are linked to a higher risk of polycystic ovary syndrome in Chinese Han women.

Finasteride-loaded proniosomes effectively promote hair growth in mice.

Insulin resistance increases the risk of developing type 2 diabetes and other health issues.

Changes in prolactin and DHEA levels are not required for the start of mink hair growth cycles.

AMH helps estimate ovarian reserve but doesn't predict pregnancy chances; age is more important.

The book concludes that despite progress, cancer drug treatments have not met the expectations set in the 1960s and 1970s.

Mice without certain skin enzymes have faster hair growth and bigger eye glands.

Fluridil safely promotes hair growth in men with androgenetic alopecia.

Fluridil safely promotes hair growth in men with androgenetic alopecia.

Updated treatments for female hair loss include minoxidil, antiandrogens, hair transplants, and light therapy.

Nandrolone and oxandrolone could help treat male health issues like muscle loss and low testosterone.

Different types of androgens bind differently to two receptors, AR1 and AR2, in Atlantic croaker's brain and ovarian tissues, suggesting these receptors may control different androgen actions in fish.

Women's hair gets thinner and grayer as they age, with treatments available for hair loss and graying.

Most women with hirsutism have it because of PCOS, and they need long-term treatment including medication and hair removal to improve their condition.

Certain natural compounds called terpenes may help prevent prostate cancer.

Exemestane may protect bones by stimulating osteoblast growth through androgen-related pathways.

RU58841 significantly increases hair growth rate and initiates more hair cycles, but doesn't affect hair thickness, suggesting it could be a new treatment for baldness.

Compounds from the Sansevieria trifasciata plant might be effective for treating hair loss.

Two non-steroidal antiandrogens, RU 58841 and RU 56187, form a common metabolite at different rates, which may influence their effects; RU 56187 could be used for prostate cancer treatment and RU 58841 for acne treatment.

PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.

Two enzymes regulate androgen receptor activity, affecting treatments for androgen insufficiency and benign prostatic hyperplasia.

LY320236 is a strong blocker of two enzymes that change testosterone into dihydrotestosterone and might help treat conditions related to male hormones.

Compound 4 is a promising treatment for hair loss with low toxicity.